AL
Anna Maria Langkilde
Highly Cited Researcher 2025
AstraZeneca, United Kingdom
Anna Maria Langkilde is a physician-scientist affiliated with AstraZeneca. Her work focuses on clinical development and medical affairs for cardiometabolic and renal therapies, including SGLT2 inhibitors. She has contributed to large-scale clinical trials in type 2 diabetes and chronic kidney disease.
- Field
- Medicine · Clinical Sciences
- Clarivate categories
- Cross-Field
- Affiliation
- AstraZeneca, United Kingdom